Preparation and evaluation of clarithromycin emulsion for injection

Yaoxue Xuebao

Volumn 41, Issue 10, 2006, Pages 945-949

  Qin, Ling Hao ^a   Tang, Xing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Clarithromycin; Emulsion; Irritation

Indexed keywords

ANTIINFECTIVE AGENT; CLARITHROMYCIN;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG FORMULATION; EMULSION; FEMALE; INJECTION; MALE; METHODOLOGY; PAIN; PAIN ASSESSMENT; PARTICLE SIZE; RABBIT; RAT; SOLUTION AND SOLUBILITY; WISTAR RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CLARITHROMYCIN; DRUG COMPOUNDING; EMULSIONS; FEMALE; INJECTIONS; MALE; PAIN; PAIN MEASUREMENT; PARTICLE SIZE; RABBITS; RATS; RATS, WISTAR; SOLUTIONS;

EID: 33845370406     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Peter DH, Clissold SP. Clarithromycin: a review of its antimicrobial activity, pharmaceutical properties and therapeutic potential [J], Drugs, 1992, 44:117-164.
2. Langtry HD, Brogden RN. Clarithromycin: a review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients [J]. Drugs, 1997, 53:973-1004.
3. Anderson R, Joone G, Rensburg EJ. An in vitro evaluation of the cellular uptake and intraphagocytic bioactivity of Clarithromycin, a new macrolide antimicrobial agent [J]. J Antimicrob Chemother, 1988, 22: 923-933.
4. Celis G, Gea E, Roig J. Comparative tolerability of intravenous erythromycin and Clarithromycin in hospitalised patients with community-acquired pneumonia results of a double-blind, randomised, prospective study [J]. Clin Drug Invest, 2002, 22:393-398.
5. Torsten Z, Heinrich L, Klaus DR, et al. Comparative tolerability of intravenous azithromycin, clarithromycin and erythromycin in healthy volunteers results of a double-blind, double-dummy, four-way crossover study [J]. Clin Drug Invest, 2001, 21:527-536.
6. Lovell MW, Johnson HW, Hui HW. Less-painful emulsion formulations for intravenous administration of clarithromycin [J]. Int J Pharm, 1994, 109:45-57.
7. Caillot D, Casasnovas O, Solary E, et al. Efficacy and tolerance of an amphotericin B lipid (intralipid) emulsion in the treatment of candidaemia in neutropenic patients [J]. J Antimicrob Chemother, 1993, 31:161-169.
8. Menashe YL, Lev L, Shoshanna GS, et al. Side-effect evaluation of a new diazepam formulation: venous sequela reduction following intravenous (iv) injection of a diazepam emulsion in rabbits [J]. Pharm Res, 1989, 6:510-516.
9. Eugene HC, Catherijen AK, Victorine SK, et al. Influence of different fat emulsion based intravenous formulation on the pharmacokinetics and pharmaco-dynamics of propfol [J]. Pharm Res, 1998, 15:442-448.
10. Toichi T, Kiyoshi K, Yoshinobu T, et al. Long circulating emulsion carrier systems for highly lipophilic drugs [J]. Biol Pharm Bull, 1994, 17:121-125.
11. Jumaa M, Muller BW. The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions [J]. Int J Pharm, 1998, 163:81-89.
12. Jumaa M, Kleinebudde P, Muller BW. Mixture experiment with the oil phase of parenteral emulsion [J]. Eur J Pharm Biopharm, 1998, 46:161-167.
13. Levy MY, Schutze W, Fuhrer C, et al. Characterization of diazepam submicron emulsion interface: role of oleic acid [J]. J Microencapsulation, 1994,11:79-92.
14. Takanura A, Ishii F, Noro S, et al. Study of intravenous hyperalimentation: effect of selected amino acids on the stability of intravenous fat emulsions [J]. J Pharm Sci, 1984, 73:91-94.
15. Celozzi E, Lotti VJ, Stapley EO, et al. An animal model for assessing pain-on-injection of antibiotics [J]. J Pharmacol Methods, 1980, 4:285-289.
16. John BC, Williams NA, Karen JP. Reduction of pain on intravenous infusion with bile salt formulations for a macrolide antibiotic [J]. Int J Pharm, 1995, 114:65-74.
17. Choong YA, Eun JK, Jong WK, et al. Effects of cysteine on the pharmacokinetics of intravenous clarithromycin in rats with protein-calorie malnutrition [J]. Life Sci, 2003, 73:1783-1794.